HomeONCO • STO
add
Oncopeptides AB
Previous close
kr 1.35
Day range
kr 1.30 - kr 1.52
Year range
kr 1.29 - kr 5.91
Market cap
118.07M SEK
Avg Volume
545.26K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 8.51M | 203.28% |
Operating expense | 69.06M | 64.43% |
Net income | -60.23M | -48.57% |
Net profit margin | -708.04 | 51.01% |
Earnings per share | — | — |
EBITDA | -60.64M | -64.80% |
Effective tax rate | 0.60% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 250.01M | 7.03% |
Total assets | 319.21M | 8.21% |
Total liabilities | 183.55M | 13.60% |
Total equity | 135.66M | — |
Shares outstanding | 215.19M | — |
Price to book | 2.14 | — |
Return on assets | -39.66% | — |
Return on capital | -54.62% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -60.23M | -48.57% |
Cash from operations | -130.48M | -125.78% |
Cash from investing | — | — |
Cash from financing | -1.96M | 15.83% |
Net change in cash | -133.26M | -121.47% |
Free cash flow | -115.01M | -171.79% |
About
CEO
Founded
2000
Website
Employees
79
